Company Overview and News

 
Robo 3D debuts on the ASX; eyes growing 3D printing market

2016-12-22 proactiveinvestors.com.au
Adding interest, Robo’s shares were last trading at $0.14, up 40% from its issue price. The California-based company has positioned itself as an emerging player in the fast-growing desktop 3D printing industry. Robo has sold almost 11,000 units of its 3D printer models in over 70 countries since delivering its first model in 2013. The company has seen consistent revenue growth each year since inception, driven by strong market share in the U.
Upvote Downvote

 
Falcon Minerals Ltd set to acquire 3D printer manufacturer

2016-09-09 proactiveinvestors.com.au
Falcon Minerals Ltd (ASX:FCN) has signed a revised agreement for the acquisition of 100% of the issued capital of Robo 3D, a U.S. based 3D printer manufacturer. The original proposed transaction was for the acquisition of 51% of Robo 3D. Founded in 2012, ROBO 3D designs, manufactures and sells desktop 3D printers and associated products to the consumer segment of the 3D printing industry. 3D printing or additive manufacturing is the process of creating three dimensional solid objects from a digital file.
Upvote Downvote

 
Grist raises $10m from Vocus share sale

2016-08-30 businessnews.com.au
Venture capitalist Anthony Grist has raised almost $10 million joining fellow board member and his private investment partner James Spenceley in selling down stakes in Vocus Communications to focus on the next generation of investments.
Upvote Downvote

 
Suspension

2016-05-04 asx.com.au
Upvote Downvote

 
Trading Halt

2016-05-02 asx.com.au
Upvote Downvote

 
Falcon Minerals Ltd to update on acquisition

2016-05-01 proactiveinvestors.com.au
Falcon Minerals Ltd (ASX:FCN) has been granted a trading halt by the ASX this morning, pending an update on the acquisition of Albion 3D Investments Pty Ltd. The halt will remain in place until the opening of trade on Wednesday 4th May 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
 
Falcon Minerals Ltd: 3D printer company acquisition signs with Staples

2016-03-23 proactiveinvestors.com.au
Falcon Minerals Ltd, (ASX:FCN) which is transitioning into the 3D printer manufacturer with a recent acquisition of  ROBO 3D, Inc., has signed a key agreement to launch into 45 U.S. retail stores of Staples, (NASDAQ:SPLS). The rollout into Staples, one of the world’s largest office supply chain stores, is another win for ROBO 3D, following the launch in October 2015 into 50 retail stores of Best Buy (NYSE:BBY).
Upvote Downvote

 
Half Year Accounts

2016-02-22 asx.com.au
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...